Litcius/Paper detail

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management

Xiao-Dong Zhou, Jeffrey V Lazarus, Chayakrit Krittanawong, Giovanni Targher, Christopher D Byrne, Zobair M Younossi, Frank Tacke, Qin-Fen Chen, Christos S Mantzoros, H Tilg, Wajahat Z. Mehal, Laurence S Sperling, Gregory Y.H. Lip, Norbert Stefan, Ming-Hua Zheng

2026˜The œLancet. Gastroenterology & hepatology11 citationsDOI

Topics & Concepts

MedicineIntensive care medicineDiseaseLiver diseaseCirrhosisSteatohepatitisPharmacotherapyFatty liverMetabolic syndromeClinical trialClinical PracticeMetabolic diseaseSteatosisAtherosclerotic cardiovascular diseaseCause of deathBioinformaticsDiabetes mellitusReview articleInsulinDrugMEDLINEType 2 diabetesLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationDiet, Metabolism, and Disease
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management | Litcius